全てのがんの早期診断目指す、シンガポールのバイオテック企業Mirxes
November 29, 2022
Singapore, 15 May 2025 – Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge Initial public offering (IPO) plans keep rolling in for Hong Kong’s